Income Taxes (Tables)

12 Months Ended

Mar. 31, 2025

Income Taxes [Abstract]

Schedule of Reconciliations of the Differences between the Income Tax Expenses

Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows:

	Year ended March 31, 2023			Year ended March 31, 2024			Year ended March 31, 2025
	RMB			RMB			RMB
Loss before income taxes		(106,805	)		(69,875	)		(59,375	)
Income tax computed at respective applicable tax rates		(26,701	)		(17,469	)		(14,844	)
Effect of different tax jurisdiction		12,323			6,976			1,590
Super deduction for research and development expenses (a)		(456	)		(547	)		(363	)
Non-deductible expenses		728			115			112
Change in valuation allowance		15,017			11,852			14,306
Total		911			927			801

(a) According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2013 onwards, enterprises engaging in research and development activities are entitled to claim 200% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 100% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2023, 2024 and 2025, the Super Deduction for research and development expenses available to the Company amounted to RMB0.5 million, RMB0.5 million and RMB 0.4 million, respectively.

Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows:

	Year ended March 31, 2023			Year ended March 31, 2024			Year ended March 31, 2025
	RMB			RMB			RMB
PRC statutory income tax rates		25	%		25	%		25	%
Tax holiday effect		(1	)%		(3	)%		(4	)%
Difference in tax rates of subsidiaries outside PRC		(10	)%		(5	)%		(4	)%
Super deduction for research and development expenses		0	%		1	%		1	%
Non-deductible expenses		1	%		0	%		0	%
Change in valuation allowance		(14	)%		(17	)%		(16	)%
Effective income tax rate		1	%		1	%		1	%

Schedule of Effect of Tax Holiday

The following table sets forth the effect of tax holiday effect on China operations:

	Year ended March 31, 2023		Year ended March 31, 2024		Year ended March 31, 2025
	RMB		RMB		RMB
Tax holiday effect		1,235		1,882		2,649
Basic and diluted net loss per share effect		0.02		0.02		0.01

Schedule of Current and Deferred Portions of Income Tax Expenses

The current and deferred portions of income tax expenses included in the consolidated statements of operations and comprehensive loss are as follows:

	Year ended March 31, 2023			Year ended March 31, 2024			Year ended March 31, 2025
	RMB			RMB			RMB
Current income tax expense/(benefit)		78			(20	)		-
Deferred tax benefit		(989	)		(907	)		(801	)
Income tax credit, net		(911	)		(927	)		(801	)

Schedule of Deferred Tax Assets and Tax Liabilities

The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2024 and 2025 are as follows:

	As of March 31,			As of March 31,
	2024			2025
	RMB			RMB
Deferred tax assets:
Net accumulated loss-carry forward		150,667			153,111
Deferred deductible advertising expense		-			83
Allowance		861			1,087
Contract liabilities		60			7
Accruals		889			261
Fair Value Change		2,778			-
Total		155,255			154,549
Less: Valuation allowance		(155,255	)		(154,549	)
Net deferred tax asset		-			-
Deferred tax liabilities:
Recognition of intangible assets arising from asset acquisition and business combination		(3,234	)		(2,433	)
Net deferred tax liabilities		(3,234	)		(2,433	)

Schedule of Movement of Valuation Allowance

Movement of valuation allowance is as follows:

	Year ended March 31, 2023			Year ended March 31, 2024			Year ended March 31, 2025
	RMB			RMB			RMB
Beginning balance		177,247			166,669			155,255
Change of valuation allowance		15,017			11,852			14,306
Written-off for expiration of net operating losses		(22,995	)		(23,266	)		(15,012	)
Decrease of valuation allowances related to the disposal of a subsidiary		(2,600	)		-			-
Ending balance		166,669			155,255			154,549